The nascent but rapidly growing krill sector is set to match or exceed 10+% point growth forecast for the entire omega-3 sector, even as public awareness remains relatively low and sustainability questions – justified or otherwise – refuse to go away.
The US arm of Israeli biotech firm Enzymotec says it is confident of sustaining double-digit growth in sales of krill oil as awareness of its multiple benefits grows.
Supplementing a high fat diet with krill oil may activate receptors that affect appetite and energy balance, suggest new findings from a mouse study with potential implications for obesity.
Another leading supplier has weighed into the debate over unscrupulous firms peddling ‘krill oil’ that contains “next to no phospholipids” but says the development of a monograph and better testing protocols might go some way to tackling the problem.
Unscrupulous firms peddling ‘krill oil’ that contains “next to no phospholipids” risk denting confidence in the efficacy of krill and the broader omega-3 market, a leading supplier has warned.
Supplementing the diet with krill oil may regulate genes in the liver and influence the production of glucose, fat and cholesterol metabolism, suggests a new study from Aker Biomarine.
Canadian krill oil firm Neptune Technologies & Bioressources aims to ratchet up production capacity from 130,000kg/year to almost 500,000kg by 2014 to meet growing demand.
The US Food & Drug Administration (FDA) has no objections regarding Aker BioMarine’s New Dietary Ingredient Notification process (NDIN) for its Superba Krill Oil ingredient.
Daily supplements of krill oil may reduce cholesterol levels by 33 percent, and improve liver triglyceride levels, with results superior to fish oil, according to data from a rat study.
Omega-3-rich krill oil may combat metabolic symptoms including raised fat levels in the heart and liver in obese individuals, says a new study partly supported by Aker Biomarine.
A detailed description of the fatty acid profile of krill oil has revealed a high content of phospholipid omega-3 fatty acid, and may aid future product development.
Daily supplements of krill oil may reduce the symptoms of arthritis, with the benefits linked to the omega-3 and antioxidant content of the ingredient, suggests a new study.
Neptune Technologies & Bioressources has recorded continued profits in its first quarter, which the firm says is partly a result of a more widespread recognition of krill oil in the nutraceutical industry.
Enzymotec has increased the omega-3 spec of its krill oil, which the firm says allows customers to declare higher levels of the fatty acids on their product labels without increasing their cost.
Omega-3s sourced from krill are more effective than fish oil in combating some metabolic symptoms including raised fat levels in the heart and liver in obese individuals, according to Italian researchers.
Israeli ingredient firm Enzymotec has opened a US subsidiary, which
the firm hopes will help it improve service to customers and
penetrate new areas of activity - particularly functional foods.
Israeli company Enzymotec has obtained GRAS status for its krill
oil, which the company hopes will allow it to commercialize the
ingredient for use in functional foods in the US.
Enzymotec has announced its entry into the krill oil market, going
head to head with market leader Neptune Krill Oil and planning
clinical research into the health benefits of its ingredient.
Neptune Technologies & Bioressources has announced the closing
of a $4.5mn private placement of common shares, which is designed
to help accelerate its business strategy and boost R&D efforts.
Neptune Technologies and Bioressources is planning a private
placement of common shares that will raise between C$3m and $4.5m
to help accelerate its business strategy and boost R&D efforts.
Canadian Neptune Technologies & Bioressources has signed a deal
with Pharmanex that will dramatically widen the distribution of
marine biomass extract Neptune Krill Oil (NKO) over the coming
year.
